1[1]Pozzo C,Basso M,Cassano A,et al.Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients.Ann Oncol 2004;15:933-939.
2[2]Seium Y,Stupp R,Ruhstaller T,et al.Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer:a phase Ⅰ-Ⅱ study.Ann Oncol 2005;16:762-766.
3[3]Cassidy J,Tabernero J,Twelves C,et al.XELOX (capecitabine plus oxaliplatin):active first-line therapy for patients with metastatic colorectal cancer.J Clin Onco12004;22:2084-2091.
4[4]Rajpal S,Venook AP.Targeted therapy in colorectal cancer.Clin Adv Hematol Oncol.2006;4:124-132.
6[6]Wong SF.Cetuximab:an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.Clin Ther 2005;27:684-694.
7[7]Masi G,Cupini S,Marcucci L,Cerri E,et al.Treatment with 5-fluorouracil/folinic acid,oxaliplatin,and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.Ann Surg Oncol 2006;13:58-65.
8[8]Sperti E,Faggiuolo R,Gerbino A,et al.Outcome of metastatic colorectal cancer:analysis of a consecutive series of 229 patients.The impact of a multidisciplinary approach.Dis Colon Rectum 2006;491596-601.
9[10]Hamady ZZ,Malik HZ,Finch R,et al.Hepatic Resection for Colorectal Metastasis:Impact of Tumour Size.Ann Surg Oncol 2006;13:1493-1499.
10[11]Adam R,Pascal G,Castaing D,et al.Tumor progression while on chemotherapy:a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052-1061.
